(March 30 20:15) Forbes.com
This Chicago-based synthetic biology / industrial chemicals business is firing on all cylinders this quarter. LanzaTech scientists have succeeded in clearing a major synbio hurdle and the management team is giving investors a reason to cheer.
You can find the original article
here